Trials / Completed
CompletedNCT00219635
Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation
A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled, Flexible Dose Study To Assess The Efficacy and Safety Of Oral UK-390,957 In Men With Premature Ejaculation
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 138 (planned)
- Sponsor
- Pfizer · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Assessment of efficacy and safety UK-390,957
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | UK-390,957 |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2005-07-01
- Completion
- 2005-07-01
- First posted
- 2005-09-22
- Last updated
- 2012-11-07
Locations
22 sites across 4 countries: United States, Australia, Canada, United Kingdom
Source: ClinicalTrials.gov record NCT00219635. Inclusion in this directory is not an endorsement.